These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34493086)

  • 1. Three-Year Clinical Outcomes Following Implantation of LifeStent Self-Expanding Nitinol Stents in Patients With Femoropopliteal Artery Lesions.
    Tan M; Takahara M; Soga Y; Mori S; Tsuchiya T; Mazaki T; Shintani Y; Noguchi M; Taniguchi M; Kobayashi Y; Nakazato J; Urasawa K
    Angiology; 2022 Mar; 73(3):244-251. PubMed ID: 34493086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-Year Clinical Outcomes following Implantation of Innova
    Tsujimura T; Takahara M; Iida O; Hiramori S; Hayakawa N; Karashima E; Miura T; Teramura M; Ichihashi K; Kojima T; Aihara H; Yamaoka T; Fujihara M; Tosaka A; Doijiri T; Mano T; Soga Y
    J Atheroscler Thromb; 2019 Oct; 26(10):847-855. PubMed ID: 30842350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-expanding nitinol stents of high versus low chronic outward force in de novo femoropopliteal occlusive arterial lesions (BIOFLEX-COF trial): study protocol for a randomized controlled trial.
    Wressnegger A; Kaider A; Funovics MA
    Trials; 2017 Dec; 18(1):594. PubMed ID: 29237489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
    Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
    J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
    [No Abstract]   [Full Text] [Related]  

  • 5. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
    Kamioka N; Soga Y; Kuramitsu S; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Suematsu N; Shintani Y; Miyashita Y; Takahashi H; Tsuchiya T; Shinozaki N; Okazaki S; Ando K
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):790-797. PubMed ID: 28722294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Statin Therapy on Restenosis in Patients Who Underwent Nitinol Stent Implantation for de Novo Femoropopliteal Artery Disease: Two-Year Follow-up at a Single Center.
    Kim W; Gandhi RT; Peña CS; Herrera RE; Schernthaner MB; Acuña JM; Becerra VN; Katzen BT
    J Vasc Interv Radiol; 2016 Oct; 27(10):1494-501. PubMed ID: 27522274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease.
    Soga Y; Takahara M; Iida O; Suzuki K; Mori S; Kawasaki D; Haraguchi K; Yamaoka T; Ando K
    J Atheroscler Thromb; 2022 Oct; 29(10):1448-1457. PubMed ID: 34911883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis.
    Sabeti S; Schillinger M; Amighi J; Sherif C; Mlekusch W; Ahmadi R; Minar E
    Radiology; 2004 Aug; 232(2):516-21. PubMed ID: 15286322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Angiographic Risk Score for Femoropopliteal Interventions.
    Iida O; Takahara M; Soga Y; Fujihara M; Kawasaki D; Hirano K; Choi D; Mano T
    J Endovasc Ther; 2020 Dec; 27(6):967-973. PubMed ID: 32813589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
    Teymen B; Akturk S; Akturk U; Tdjani M
    Vascular; 2018 Feb; 26(1):54-61. PubMed ID: 28708023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis.
    Iida O; Soga Y; Hirano K; Suzuki K; Yokoi H; Nobuyoshi M; Muramatsu T; Inoue N; Nanto S; Uematsu M
    J Endovasc Ther; 2011 Dec; 18(6):753-61. PubMed ID: 22149222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-Year Clinical Outcomes of the Innova™ Self-Expanding Nitinol Stent for the Treatment of Femoropopliteal Lesions.
    Karashima E; Takahara M; Hozawa K; Yamauchi Y; Suzuki K; Suematsu N; Miyashita Y; Enomoto S; Tokuyama H; Murata N; Haraguchi K; Soga Y
    Cardiovasc Intervent Radiol; 2021 Nov; 44(11):1722-1727. PubMed ID: 34523023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries.
    Sabeti S; Mlekusch W; Amighi J; Minar E; Schillinger M
    J Endovasc Ther; 2005 Feb; 12(1):6-12. PubMed ID: 15683273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.
    Armstrong EJ; Jeon-Slaughter H; Kahlon RS; Niazi KA; Shammas NW; Banerjee S
    J Endovasc Ther; 2020 Feb; 27(1):60-65. PubMed ID: 31686573
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
    Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
    J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.